|Articles|December 1, 1996

Pharmacoeconomic and Healthcare Outcomes Research: Managing and Treating Hypertension and Cardiovas
Volume 2
Issue 12 Suppl

Felodipine as an Alternative to More Expensive Calcium Antagonists in Mild to Moderate Hypertension

Author(s)Major Frank J. Landry, MD, MPH, Captain J. David Horwhat, MD, David Tomich, PharmD

Download PDF: Felodipine as an Alternative to More Expensive Calcium Antagonists in Mild to Moderate Hypertension

Articles in this issue

about 29 years ago

Article

Introduction

about 29 years ago

Article

Process and Outcome of Outpatient Management of Heart Failure: A Comparison of Cardiologists and Primary Care Providers

about 29 years ago

Article

Gatekeepers and Managed Care: Too Much of a Good Thing?

about 29 years ago

Article

Clinical Outcome of a Mandatory Formulary Switch for Dihydropyridine Calcium Channel Blocker Therapy at a Veteran's Administration Medical Center

about 29 years ago

Article

An Analysis of Costs and Complications of Monophasic and Biphasic Implantable Cardioverter Defibrillators

about 29 years ago

Article

Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group

about 29 years ago

Article

Aspirin after Myocardial Infarction: Patient Experience in a Managed Care Setting

about 29 years ago

Article

MANAGED CARE CLINICAL CORNER: Chest Pain

about 29 years ago

Article

Selected Abstracts

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Felodipine as an Alternative to More Expensive Calcium Antagonists in Mild to Moderate Hypertension

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

New Multiple Myeloma Therapies Offer Hope for Potential Cure: Ameet Patel, MD